Your browser doesn't support javascript.
loading
Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy.
Cortellini, A; Ricciuti, B; Facchinetti, F; Alessi, J V M; Venkatraman, D; Dall'Olio, F G; Cravero, P; Vaz, V R; Ottaviani, D; Majem, M; Piedra, A; Sullivan, I; Lee, K A; Lamberti, G; Hussain, N; Clark, J; Bolina, A; Barba, A; Benitez, J C; Gorría, T; Mezquita, L; Hoton, D; Aboubakar Nana, F; Besse, B; Awad, M M; Pinato, D J.
Affiliation
  • Cortellini A; Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy; Division of Cancer, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK. Electronic address: a.cortellini@imperial.ac.uk.
  • Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
  • Facchinetti F; Université Paris-Saclay, Institut Gustave Roussy, Inserm, Biomarqueurs Prédictifs et Nouvelles Stratégies Thérapeutiques en Oncologie, Villejuif, France.
  • Alessi JVM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
  • Venkatraman D; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
  • Dall'Olio FG; Cancer Medicine Department, Gustave Roussy, Villejuif, France.
  • Cravero P; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
  • Vaz VR; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
  • Ottaviani D; Cancer Division, University College London Hospitals, London, UK.
  • Majem M; Medical Oncology Department, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain.
  • Piedra A; Medical Oncology Department, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain.
  • Sullivan I; Medical Oncology Department, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain.
  • Lee KA; Department of Medical Oncology, Royal Marsden Hospital, London, UK; Department of Twin Research and Genetic Epidemiology, St Thomas's Hospital, King's College London, London, UK.
  • Lamberti G; Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Alma Mater Studiorum University of Bologna, Bologna, Italy.
  • Hussain N; Division of Cancer, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK.
  • Clark J; Division of Cancer, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK.
  • Bolina A; Division of Cancer, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK.
  • Barba A; Medical Oncology Department, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain.
  • Benitez JC; Cancer Medicine Department, Gustave Roussy, Villejuif, France.
  • Gorría T; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain.
  • Mezquita L; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain.
  • Hoton D; Department of Pathology, Cliniques universitaires Saint-Luc, Brussels, Belgium.
  • Aboubakar Nana F; Institut de Recherche Expérimentale et Clinique (IREC), Pôle de Pneumologie, ORL et Dermatologie (PNEU), Université catholique de Louvain (UCLouvain), Brussels, Belgium.
  • Besse B; Cancer Medicine Department, Gustave Roussy, Villejuif, France; University Paris-Saclay, School of Medicine, Villejuif, France.
  • Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
  • Pinato DJ; Division of Cancer, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Ann Oncol ; 32(11): 1391-1399, 2021 11.
Article in En | MEDLINE | ID: mdl-34400292
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Anti-Bacterial Agents Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Ann Oncol Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Anti-Bacterial Agents Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Ann Oncol Year: 2021 Document type: Article